Evidence map›Paper›PMID 22393262›Full record

ArticleMolecular & cellular proteomics : MCP2012

Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins.

Benjamin F Mann, John A Goetz, Michael G House, C Max Schmidt, Milos V Novotny

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. N-Glycan profiling of lung adenocarcinoma in patients at different stages of disease.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020
    Article
  7. Review
  8. Article
  9. Clinical application of quantitative glycomics.Expert review of proteomics · 2018
    Review
  10. Review
  11. Article
  12. Glycoproteins and glycoproteomics in pancreatic cancer.World journal of gastroenterology · 2016
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Systematic Review of Pancreatic Cyst Fluid Biomarkers: The Path Forward.Clinical and translational gastroenterology · 2015
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Benjamin F MannChemistry Department of Indiana University, Bloomington, Indiana 47405, USA.
John A Goetz
Michael G House
C Max Schmidt
Milos V Novotny
Indiana University Bloomington · USIndiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Early Cancer Detection & Prognosis through GlycomicsU01CA128535 · NCI · TRUSTEES OF INDIANA UNIVERSITY · PI NOVOTNY, MILOS · 2007 to 2011
$1.9M
NCI NIH HHS U01 CA128535
6 · The paper itself

Abstract

Pancreatic cancer is now the fourth leading cause of cancer deaths in the United States, and it is associated with an alarmingly low 5-year survival rate of 5%. However, a patient's prognosis is considerably improved when the malignant lesions are identified at an early stage of the disease and removed by surgical resection. Unfortunately, the absence of a practical screening strategy and clinical diagnostic test for identifying premalignant lesions within the pancreas often prevents early detection of pancreatic cancer. To aid in the development of a molecular screening system for early detection of the disease, we have performed glycomic and glycoproteomic profiling experiments on 21 pancreatic cyst fluid samples, including fluids from mucinous cystic neoplasms and intraductal papillary mucinous neoplasms, two types of mucinous cysts that are considered high risk to undergo malignant transformation. A total of 80 asparagine-linked (N-linked) glycans, including high mannose and complex structures, were identified. Of special interest was a series of complex N-linked glycans containing two to six fucose residues, located predominantly as substituents on β-lactosamine extensions. Following the observation of these "hyperfucosylated" glycans, bottom-up proteomics experiments utilizing a label-free quantitative approach were applied to the investigation of two sets of tryptically digested proteins derived from the cyst fluids: 1) all soluble proteins in the raw samples and 2) a subproteome of the soluble cyst fluid proteins that were selectively enriched for fucosylation through the use of surface-immobilized Aleuria aurantia lectin. A comparative analysis of these two proteomic data sets identified glycoproteins that were significantly enriched by lectin affinity. Several candidate glycoproteins that appear hyperfucosylated were identified, including triacylglycerol lipase and pancreatic α-amylase, which were 20- and 22-fold more abundant, respectively, following A. aurantia lectin enrichment.

Indexed as

Agedalpha-AmylasesAmino SugarsBiopsy, Fine-NeedleChromatography, AffinityCystadenoma, MucinousCyst FluidEarly DiagnosisFemaleFucoseGene ExpressionGlycomicsGlycoproteinsHumansLectinsLipasealpha-AmylasesAmino SugarsFucoseGlycoproteinslectin, Aleuria aurantiaLectinsLipasePolysaccharides

Identifiers

PMID22393262
PMCPMC3394951
OpenAlexW2138079571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.